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DNA methylation and differential gene regulation
in photoreceptor cell death
P Farinelli1,2, A Perera3, B Arango-Gonzalez2, D Trifunovic2, M Wagner4, T Carell4, M Biel3, E Zrenner2, S Michalakis*,3,
F Paquet-Durand*,2 and PAR Ekström1
Retinitis pigmentosa (RP) defines a group of inherited degenerative retinal diseases causing progressive loss of photoreceptors.
To this day, RP is still untreatable and rational treatment development will require a thorough understanding of the underlying cell
death mechanisms. Methylation of the DNA base cytosine by DNA methyltransferases (DNMTs) is an important epigenetic factor
regulating gene expression, cell differentiation, cell death, and survival. Previous studies suggested an involvement of epigenetic
mechanisms in RP, and in this study, increased cytosine methylation was detected in dying photoreceptors in the rd1, rd2, P23H,
and S334ter rodent models for RP. Ultrastructural analysis of photoreceptor nuclear morphology in the rd1 mouse model for RP
revealed a severely altered chromatin structure during retinal degeneration that coincided with an increased expression of the
DNMT isozyme DNMT3a. To identify disease-specific differentially methylated DNA regions (DMRs) on a genomic level, we
immunoprecipitated methylated DNA fragments and subsequently analyzed them with a targeted microarray. Genome-wide
comparison of DMRs between rd1 and wild-type retina revealed hypermethylation of genes involved in cell death and survival as
well as cell morphology and nervous system development. When correlating DMRs with gene expression data, we found that
hypermethylation occurred alongside transcriptional repression. Consistently, motif analysis showed that binding sites of several
important transcription factors for retinal physiology were hypermethylated in the mutant model, which also correlated with
transcriptional silencing of their respective target genes. Finally, inhibition of DNMTs in rd1 organotypic retinal explants using
decitabine resulted in a substantial reduction of photoreceptor cell death, suggesting inhibition of DNA methylation as a potential
novel treatment in RP.
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Retinitis pigmentosa (RP) refers to a heterogeneous group
of inherited retinal degenerations that provoke progressive
and irreversible loss of photoreceptors. In the developed
countries, RP represents the leading cause for severe vision
loss and blindness among young people.1 Currently, muta-
tions in 450 genes have been linked to RP (https://sph.uth.
tmc.edu/retnet/), but the mechanisms that lead to photo-
receptor death are still unresolved, and there is no treatment
available. RP therapy development is severely limited by the
high genetic heterogeneity, which therefore calls for the
identification of common disease mechanisms and drug
targets.
A previous microarray study showed a dramatic modification
in gene expression when the rd1 mouse model for RP was
compared with wild-type (wt) animals.2 Such profound effects
on gene expression are probably a consequence of both
pro-survival responses and induction of cell death pathways.
Alterations of gene expression are often linked to epigenetic
events, such as acetylation and poly-ADP-ribosylation of
histones. In this regard, we have previously found the activity
of both histone deacetylase (HDAC) and poly-ADP-ribose-
polymerase (PARP) to be causally involved in retinal
degeneration.3,4 Although these epigenetic regulators func-
tion via modification of the chromatin structure, direct
methylation of the DNA5,6 is another powerful factor in
epigenetic regulation of gene expression. DNA methylation
was recently connected with retinal degeneration and retinal
development.7 However, it is still unknown if and how DNA
methylation patterns vary between different genes in healthy
and diseased tissues and whether an interference with
DNA methylation would be beneficial for degenerating
photoreceptors.
The covalent addition of a methyl group on cytidines
followed by guanosine in the DNA is performed by various
DNA methyltransferases (DNMTs) such as DNMT1,
DNMT3A, and DNMT3B,8,9 while DNMT3L may stimulate
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de novo DNA methylation.10 Methylation occurs mainly in
gene promoters but can also be seen in intergenic non-
coding regions and within genes.11 DNA methylation is
generally associated with repression of transcription.12
Here, we have compared retinal DNA methylation in the rd1
mouse model,13 with those of healthy, congenic wt mice and
correlated DNA methylation changes with gene expression
data sets. We then used an organotypic retinal explant system
to evaluate the effect of a DNA methylation inhibitor on rd1
photoreceptor survival in vitro. We furthermore analyzed the
extent of DNA methylation in three other RP models, namely
the rd2 mouse and the S334ter and P23H transgenic rats. All
four RP models represent mutations that are similar to the
ones found in certain cohorts of patients.14–16
Our data show an increase in DNA methylation in dying
photoreceptors in all four RP animal models analyzed,
suggesting DNA hypermethylation as a common denominator
in the photoreceptor degeneration pathway. Moreover, our
results reveal that in rd1 retinae specific genes may be either
hypomethylated or hypermethylated. Pharmacological inhibi-
tion of DNMTs significantly reduced rd1 photoreceptor cell
death in short-term experiments but did not increase cell
survival in the long-term experiments. Our findings thus
suggest a complex relation between DNA methylation and
retinal degeneration, which may include both disease-driving
and disease-counteracting elements.
Results
rd1 photoreceptors show abnormal chromatin structure.
Epigenetic modifications, such as DNA methylation, manifest
themselves in chromatin rearrangements. For an initial
assessment, we performed an analysis of photoreceptor
nuclei ultrastructure in PN11 rd1 and wt retinae. Nuclei of
both rd1 and wt photoreceptors (Figure 1a) contain both
dense heterochromatin (dark in the EM micrographs) with low
transcriptional activity and loose euchromatin (light in the
micrographs) with high transcriptional activity. This is normal
for mouse photoreceptor nuclei at this age, although adult rod
nuclei in contrast to other cells display an inversed nuclear
architecture, that is, their euchromatin is collected closest to
the nuclear envelope and the heterochromatin placed in the
center of the nuclei.17
A subset of rd1 photoreceptor nuclei had a different
appearance, and their chromatin and nuclear characteristics
could be roughly categorized into four general stages
(Figure 1b). Initially, rd1 photoreceptor nuclei appear normal,
comparable to wt, with a clear density difference between
heterochromatin and euchromatin, and with ‘fuzzy’ borders of
the heterochromatin. rd1 nuclei, which had an elongated form
and normal size but displayed a darker euchromatin and
sharper heterochromatin borders, were categorized as Stage
1. rd1 nuclei, with a smaller and rounded appearance, and
with proportionally much more heterochromatin, with sharp
borders were labeled as Stage 2. Some stage 2 nuclei also
showed a euchromatin-containing area at their rim (Figure 1b).
Stage 3 nuclei were in principle homogenously dark with only
heterochromatin and were either round or irregular in shape
and much smaller than normal nuclei. Stage 3 may represent
the final phase of photoreceptor death, as they resemble the
small terminal-dUTP-nick-end-labeling (TUNEL)-positive cells
frequently observed in rd1 specimens of this age (see, e.g.,
Figure 4 in Sancho-Pelluz et al.4). Taken together, the nuclear
structure of the degenerating rd1 photoreceptors is severely
altered.
DNA methylation is increased in dying photoreceptors.
To study photoreceptor DNA methylation in situ, we used
immunofluorescence with an anti-5-methylcytosine (5mC)
antibody. 5mC-positive rd1 nuclei were most often round and
also frequently smaller than their negative counterparts
(Figures 1c and d). Combined with the EM data, this could
indicate that DNA hypermethylation occurs primarily at later
stages of rd1 photoreceptor death (i.e., Stages 2 and 3 in
Figure 1b). The 5mC signal was commonly localized to the
nuclear rim (arrows in Figures 1c and d) or had a very
condensed appearance (arrowheads in Figures 1c and d).
Remarkably, 5mC appeared to avoid the most DAPI-dense
parts of the nuclei, including supposed chromocenters
(asterisk in Figure 1c). As DAPI is a dye that binds to the
minor groove of the DNA,18 5mC-positive DNA may have lost
its conventional confirmation and minor groove resulting in a
DAPI-negative staining.
In rd1 retina, alterations of nuclear morphology correlate
with increased HDAC activity,4 and we therefore assessed
protein acetylation together with DNA hypermethylation.
Interestingly, three different rodent RP models (rd1 mouse,
S334ter, and P23H rats) displayed 5mC labeling in cells with
lysine hypoacetylation (Figure 2), that is, with overactivated
HDACs,4,16 indicating that more than one epigenetic event
may simultaneously affect degenerating photoreceptors.
Strong immunoreactivity for methylated DNA was only
rarely found in any retinal cell layer of wt animals or in the
inner retinal layers in rd1 animals. By contrast, a distinct
subset of cells in the rd1 outer nuclear layer (ONL) had clearly
labeled nuclei (Figure 3a), that were observed also in other
models for RP, including the rd2mouse. In all of these models,
and in line with the rd1 data, a sub-population of photo-
receptors showed an increase of nuclear DNA methylation at
the evaluated time points compared with wt counterparts
(Figures 3b–d). This suggested increased DNAmethylation as
a general phenomenon during inherited photoreceptor
degeneration.
In all the analyzed models, the TUNEL assay for dying cells
co-labeled the 5mC-positive cells to a great extent, suggesting
an intimate connection between increased DNA methylation
and the degeneration of the photoreceptors (Figures 3a–d).
Moreover, the various models have different degeneration
kinetics, which leads to different numbers of dying photo-
receptor cells at their respective peak of degeneration.16,19,20
Yet, the amount of 5mC-positive ONL cells reflected the
amount of TUNEL-positive cells faithfully (Figures 3a–d),
again indicating that the DNA hypermethylation was somehow
related to the degeneration.
To better understand the temporal dynamics of the photo-
receptor DNA methylation, we analyzed 5mC immunoreactiv-
ity in rd1 retinal sections from PN7 to PN15 and compared it
with the progression of cell death as evidenced by TUNEL
staining (Figure 4a). Although very low at PN7, the number of
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Figure 1 Altered rd1 nuclear ultrastructure and DNA methylation. (a) The overview of PN11 wt and rd1 ONL illustrates the mixed distribution of heterochromatin and
euchromatin (dark and light areas, respectively) in both wt and (most) rd1 photoreceptor nuclei. Typical examples of such nuclei are pointed out by red arrows. By contrast, rd1
photoreceptor nuclear configurations varied considerably from ‘normal’ (= similar to wt nuclei), via the different stages 1 and 2, to very condensed, electron dense and dark, that
is, stage 3 (blue arrow in rd1 picture). These stages are shown in more detail in panel (b). (c and d) In rd1 PN11 retina, immunostaining for 5mC (green), together with a nuclear
counterstain (4,6-diamidino-2-phenylindole (DAPI), blue), showed varying degrees of co-localization. 5mC-positive structures had a DAPI appearance that was either
heterogeneous rounded (*), or homogenous rounded (arrows), or weak to the point of being absent (arrowheads), most likely reflecting the different stages of nuclear
condensation identified in panel (a). The confocal images in c and d are maximum projections of 16 and 21 Z-sections, respectively. Scale bars: a, c, and d= 10 μm, b= 2 μm
Figure 2 DNA methylation colocalizes with protein deacetylation. Loss of lysine acetylation can mark HDAC activation (Sancho-Pelluz et al.4). Stainings for 5mC and lysine
acetylation (Ac. lysines) were here combined, which resulted in that 5mC staining often occurred in nuclei where acetylated lysines were very low or absent, suggesting an
interplay between HDAC and DNMTactivities. This was seen in (a) rd1mouse, as well as in (b) S334ter and (c) P23H rat retinae. ONL: the individual figures are oriented such that
this layer is up and inner retinal layers are down. Scale bar= 20 μm. The results are representative for observations made in at least three different individuals of each genotype
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5mC-positive cells strongly increased until PN13 (degenera-
tion peak) to then decrease at PN15. The temporal dynamics
of DNA methylation versus rd1 TUNEL staining thus pointed
to DNA methylation being a late event in photoreceptor
cell death.
DNA methylation coincides with increased DNMT
expression. To test whether the observed hypermethyla-
tion was caused by increased expression of DNMTs, we
applied quantitative reverse transcription-PCR (qRT-PCR)
of different DNMTs in PN11 rd1 and wt retinae. DNMT3A
(3.5± 0.9 arbitrary units (a.u.)) and DNMT3L (4.1± 0.6)
were found to be upregulated in the rd1 mutants when
compared with age-matched wt (1.0± 0.2 and 1.1± 0.6 a.u.,
respectively, Po0.05). No alterations in the gene
expression of DNMT1 and DNMT3B were detected
(Figure 4b).
To study DNA methylation also at the tissue level, we
employed high-performance liquid chromatography (HPLC)
coupled with mass spectrometry on global retinal samples to
yield the percentage of methylated cytidines within the
samples. The results suggest that from a quantitative point
the DNA methylation is unchanged at the global tissue level
(wt=3.27%±0.08; rd1=3.25%± 0.04; n= 5 for both geno-
types). The results from this tissue-based approach thus are in
contrast to the results obtained with the cellular approach
Figure 3 DNAmethylation colocalizes with cell death in four different RP animal models. An immunostaining for 5mC was performed together with the TUNEL assay for dying
cells in four animal models for RP. In these models, co-staining was performed at time points corresponding to the onset or peak of retinal degeneration. In (a) PN11 rd1 and (b)
PN19 rd2mouse retina, as well as in (c) PN12 S334ter and (d) PN19 P23H rat retina, the numbers of 5mC immunodecorated photoreceptors was increased when compared with
wt controls and most of the 5mC-positive cells were co-labeled with the TUNEL assay. GCL= ganglion cell layer; INL= inner nuclear layer. Scale bar= 20 μm. The results are
representative for observations made in at least three different individuals of each genotype
DNA methylation in inherited retinal degeneration
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above, which could indicate that the relatively low number of
cells showing strong DNAmethylation may not be picked up at
the whole tissue level.
DNA methylation affects different genomic regions in rd1
and wt. In a qualitative approach, we assessed the genomic
localization of 5mC in wt and rd1 retinae by performing a DNA
methylation microarray (2.1M Deluxe Promoters, Nimble-
Gen). We used the cistrome platform (http://cistrome.org/ap/)
to identify peak enrichment (MA2C tool) and performed
further analysis. First, we calculated the Pearson correlation
coefficients to correlate rd1 and wt signal profiles that were
restricted to methylated genomic regions. We detected 77%
overlap of methylated regions in rd1 and wt, suggesting that
there are differentially methylated regions in rd1 mice in
comparison to wt (Figure 5a).
Mapping the peak location to genes using the peak2gene
tool of the cistrome platform, we detected 1727 genes equally
methylated in both groups but 95 genes that were hypomethy-
lated in the rd1. However, this alteration was outbalanced by
the detection of 1284 hypermethylated genes in rd1, which
indicated increased DNA methylation in intragenic regions
(Figure 5b,Supplementary Table S1). Gene ontology analysis
revealed strong methylation enrichment of genes related to
nervous system development and function, cellular assembly,
organization, function, and maintenance as well as cell death,
survival, and morphology (Figure 5c).
Moreover, k-means clustering revealed that methylation
enrichment appeared to be stronger in specific genomic
regions in the rd1 retina (Supplementary Table S1). Example
data on the distribution of average signal plots of 5mC reads on
different genomic regions are visualized in Figures 5d and e.
To further investigate the differential distribution on hyper-
methylated sites, we investigated the average exon profile in
wt and rd1 mice (Figures 5f and g). Remarkably, we detected
stronger exonic methylation in rd1 irrespective of its relative
location within the exon. The meta-gene plot in rd1 and wt
(Figure 5h) revealed prominent promoter methylation in both
rd1 and wt. However, we also detected increased gene body
methylation toward the 3′ end in rd1 retina.
Motif enrichment of hypermethylated rd1 sites and gene
expression correlation. Transcription factor binding to the
DNA may be sensitive to the methylation status of its
respective binding site.21,22 Therefore, we used the cistrome
platform (Sitepro tool) to further investigate whether 5mC was
enriched in specific transcription factor-binding sites. Hyper-
methylation in rd1 mice was enriched in specific binding
motifs of transcription factors, including Yin Yang 1 (YY1),
E2F transcription factor 3 (E2F3), and neural retina-specific
leucine zipper protein (NRL) (Figures 6a–g, Supplementary
Table S2). For the possible connection with RP, it is
interesting to note that YY1 can interact with HDACs, is itself
regulated by acetylation,23 and may be photoreceptor specific
in the retina.24 E2F3, on the other hand, might contribute to
rod photoreceptor cell death in the rd1 model.25 Furthermore,
NRL mutations are associated with autosomal-dominant
RP.26 We thus analyzed the methylation status of potential
YY1, E2F3, and NRL target genes (Supplementary Table
S3). For YY1, we detected 351 target genes, of which 19
were methylated in wt only and 140 had a conserved
methylation pattern in the transcription factor-binding sites
between the two genotypes. However, the majority (192 of
351) of YY1 target genes were methylated in rd1 only
(Figure 6c). We detected a similar pattern for NRL target
genes (8, 128, and 146 out of 282; wt, conserved, and rd1,
respectively; Figure 6e) and E2F3 (8, 103, and 130 out of
242; wt, conserved, and rd1, respectively; Figure 6g)
target genes.
We then studied the relationship between 5mC and gene
expression during retinal degeneration, for which we went
back to the original gene expression raw data from a previous
microarray experiment2 and correlated this with the hyper-
methylated genes seen here. Global correlation analysis
revealed that genes carrying methylated regions in the
promoter or gene body were expressed at significantly lower
levels compared with unmethylated genes (Student’s t-test,
Po0.005; Figure 6h). The same was true for the subgroups of
YY1, E2F3, and NRL target genes (Student’s t-test, Po0.05,
Po0.01, and Po0.05, respectively; Figure 6h). Together, this
Figure 4 Temporal dynamics of DNA methylation and DNMT gene expression.
(a) In rd1 ONL, at early PN ages, the numbers of photoreceptors showing 5mC
staining were very low, increased from PN11 onwards, and peaked at PN13. The
temporal progression of 5mC positivity in rd1 ONL corresponded largely to the extent
of cell death as evidenced by TUNEL staining, implying a close connection between
DNA methylation and cell death. (b) Quantitative reverse transcriptase–PCR analysis
of different DNMT mRNAs showed a statistically significant upregulation of DNMT3A
and DNMT3L expression in rd1 retina. Data points in panel (a) represent the
percentage of relative positive cells (peak value= 100%)± S.D., with n= 3–4. Bars
in panel (b) represent mean±S.D., n= 3, with arbitrary units (arb. un.) for mRNA
expression (wt= 1). Values were compared using the Student’s t-test. *Po0.05,
**Po0.01
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suggested that hypermethylation of genes and their regulatory
regions correlated with transcriptional repression in the rd1
retina.
DNMT inhibition delays rd1 photoreceptor degeneration
in vitro. Our study based on immunofluorescence provided
strong evidence for a disease-induced increase of DNA
methylation in rd1 photoreceptors. DNMTs can be pharma-
cologically inhibited with cytidine-nucleotide analogues.27,28
Among those, 5-aza-2’-deoxycytidine (decitabine) has been
reported to reduce DNA methylation and restore gene
expression patterns in human neuronal cell lines29 and
showed promising results towards the treatment of prolifera-
tive diseases.30,31 We therefore investigated whether
Figure 5 Genomic distribution of 5mC in rd1 and wt mice at PN11. (a) Correlation plot of methylation distribution between wt and rd1 retinae at PN11. Venn diagram of
differentially methylated genes in wt (violet) and rd1 (red), showing 1284 genes to be hypermethylated in rd1, whereas only 95 genes are hypomethylated. (b) Additionally, 1727
genes have conserved methylation patterns. (c) Gene ontology analysis of genes methylated in rd1 retina. (d) Heatmap representations of 5mC enrichment in identified peak
regions (5 kb flanking the transcription start site (TSS), which is the 5′ position of a gene sequence, where transcription starts). (e) Exemplified composite profiles for different
clusters. Composite signal profiles of 5mC patterns in genes characterized by 5mC enrichment or lack of 5mC enrichment in concatenated exons in (f) the wt and (g) the rd1
retina. The methylation profiles for wt and rd1 reveal stronger methylation of exons in rd1, independent of the relative distance within the exon (f and g). (h) Overlayed average
gene methylation profiles in wt and rd1 retina. Note the 5mC enrichment at gene promoter regions (500 bp upstream, i.e., left of TSS) for both genotypes, and in gene body
towards 3′ end of the gene in rd1 (approximately 2000–3500 downstream, i.e., right of TSS) (h). Grey areas in (f–h) indicate regions without 5mC enrichment
DNA methylation in inherited retinal degeneration
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decitabine had any effects on photoreceptor cell survival
using rd1 organotypic retinal explant cultures.
Retinae from rd1 animals received treatment with 0.5, 1.25,
2.5, 5, or 10 μM decitabine for 4 days (short-term cultures,
ending at postnatal (PN) day 11, Figures 7a and b; see
Material and Methods section for further details on culturing
paradigms). Although all concentrations tested reduced the
number of TUNEL-positive cells, treatment with 2.5 μM
decitabine was most powerful and reduced the number of
dying cells by 48% (control=4.8%± 0.7; 2.5 μM decitabine
treated=2.5%±0.5; Po0.05). Quantification of the numbers
of 5mC-positive cells revealed a reduction of around 41% in
the treatment group compared with untreated controls
(Figures 7c and d; control= 3.0%±0.6; 2.5 μM decitabine
treated=1.8%±0.6; Po0.05), indicating that decitabine
treatment indeed reduced DNA methylation.
We next analyzed whether DNMT inhibition promoted
photoreceptor cell survival in long-term organotypic cultures
treated with 2.5 μM decitabine. After 12 days of treatment
(ending at PN19), both groups exhibited the same number
of surviving photoreceptor rows (control=3.4±0.6 rows;
treated=3.4±0.3; n= 6; P40.05).
Discussion
Our work highlights the importance of DNA methylation for
neuronal cell death in the retina. Increased DNA methylation
was detected in four different models for retinal degeneration
representing mutations of varying kinds and with most likely
various entry points into the degeneration processes.
Together with earlier studies,7 our data points to DNA
hypermethylation as a common denominator in inherited
photoreceptor degeneration.
DNA methylation and gene regulation. We found that DNA
methylation was most prominent and reached ‘catastrophic’
intensities during the final stages of cell death. However, we
cannot exclude that hypermethylation of specific genes may
be starting far earlier. For instance, we observed alterations in
DNA methylation at the level of individual genes, including
Figure 6 Motif enrichment of methylation patterns and gene expression correlation. (a) The list shows the top 20 of motifs enriched in rd1 retina at PN11. Globally enriched
motifs in methylated regions in rd1 retina at PN11 for (b) YY1, (d) NRL, and (f) E2F3. Venn diagrams of methylated genes containing binding motifs for (c) YY1, (e) NRL, and (g)
E2F3 in wt and rd1. (h) Gene expression profile of methylation unaltered (conserved) genes and hypermethylated genes in rd1. Bars represent mean± S.E.M., n= 3, of log2
(gene) expression ratios. Pairs of groups were compared using the Student’s t-test. *Po0.05, **Po0.01, ***Po0.005
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hypermethylation of the important transcription factors
YY1, E2F3, and NRL. As we also noted a transcriptional
repression of their target genes, this process should have
required some time and hence the hypermethylation of the
transcription factors is likely to have happened before the cell
entered the final phase of cell death. Bearing in mind the
nature of YY1, E2F3, and NRL target genes, this could have
far-reaching effects, leading to critical dysregulation of
cellular events to precipitate photoreceptor cell death.
Moreover, hypermethylation may occur in synergy with
other epigenetic events, as it coincided with low acetyla-
tion, suggesting a simultaneously increased HDAC activity.
This goes well with the many interconnections between
DNA methylation and HDAC events,10,32,33 which may
reinforce each other in preventing transcription.34 We
therefore propose that degenerating photoreceptors
trigger an epigenetic program that includes de novo
DNA methylation to shut down transcription and protein
biosynthesis to minimize energy expenditure during
cell death.
Interestingly, we also noted several hypomethylated genes
suggesting that demethylation of methylcytosine may also
have a role during photoreceptor cell death. However, it
remains elusive if demethylation is triggered by active
DNA demethylation via hydroxylase activity of ten eleven
translocation (Tet) enzymes, DNA repair, or oxidative damage
during photoreceptor degeneration.
DNA methylation as a novel target for retinal neuro-
protection. The use of (non-decitabine) DNMT inhibitors to
reduce DNA methylation has previously been proposed to
be neuroprotective in motor neurons in vivo as well as in a
neuronal cell line in vitro.35 Yet, Wang et al.36 reported
neurotoxicity by decitabine in cultured dopaminergic cells.
We evaluated the role of DNMTs in the degeneration
process by treating organotypic rd1 retinal explant cultures
Figure 7 Short-term DNMT inhibition protects rd1 photoreceptor in vitro. (a and b) Treatment with the DNMT inhibitor decitabine for 4 days in vitro significantly reduced
photoreceptor cell death (expressed as the percentage of TUNEL-positive cells in the ONL). (c and d) At 2.5 μM, decitabine also reduced the numbers of 5mC-positive cells. Bars
represent mean±S.D., n= 2–7, and values were compared using the Student’s t-test. **Po0.01, ***Po0.005; ONL: the individual figures are oriented such that this layer is up
and inner retinal layers are down. Scale bar= 20 μm. See Material and Methods section for culturing paradigm details
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with decitabine. Although decitabine did not increase the
number of surviving photoreceptors in long-term cultures, in
short-term experiments it reduced DNA hypermethylation
and decreased the number of dying photoreceptors. This
effect of decitabine is intriguing, considering its mode of
action: A cytidine analogue of decitabine is thought to be
incorporated into newly synthesized DNA.37 This reduces
the possibilities for de novo methylation by DNMTs in any
new DNA, such as in daughter cells of proliferating cells. In
addition, decitabine can promote the degradation of DNMT
enzymes,37 to result in an overall reduction of DNA
methylation.
At any rate, the protective effects of decitabine in short-term
treatment confirm the causal involvement of DNA methylation
in rd1 photoreceptor cell death. As this delay in rd1
degeneration does not manifest itself in the long term, massive
DNA methylation likely occurs during the final stages of
cell death.
DNA methylation during photoreceptor cell death.
Although the mechanisms of photoreceptor cell death remain
elusive, in recent years the focus has shifted from apoptotic
processes38 to non-apoptotic pathways.39 In particular, a
number of epigenetic events have been causally associated.
This includes the excessive activation of PARP1 and PARG
and accumulation of PARylated proteins3,40,41 as well as
over-activation of HDAC and hypoacetylation of proteins, in
particular histones.4 Remarkably, deacetylation and exces-
sive PARylation appeared to be occurring in sequence in the
same cell, that is, deacetylation of proteins was followed by
PARylation.4 Our current findings add DNA hypermethylation
to this picture, which also appears prominently in cells that
show very low protein acetylation. This corresponds to the
known connections between DNA methylation and epigenetic
protein modifications.10,32,42 DNA methylation and HDAC
activities could, for instance, cooperate to prevent the
mentioned transcription factors from acting.
The exact type of DNMT responsible for rd1 photoreceptor
DNA hypermethylation will have to be determined in future
studies. DNMT1was found to be related to survival rather than
cell death, as lack of DNMT1 caused a relatively rapid
photoreceptor degeneration.43 However, the observed upre-
gulation of DNMT3A mRNA in the rd1 retina suggests that this
DNMT is a candidate for mediating increased methylation.
This is in line with the de novo methyltransferase activity of
DNMT3A, which could additionally complement and correct
DNMT1 enzymatic activity,12 modifying cytosines in newly
synthesized non-methylated DNA. Additionally, overexpres-
sion of DNMT3A, but not DNMT1, triggered cell death in a
neuronal cell line.35
Asmentioned above, decitabine is thought to be incorporated
into newly synthesized DNA.37 However, the retinal photo-
receptors are regarded as postmitotic neurons and are, as
such, not expected to synthesize large amounts of DNA outside
their development. Nevertheless, incorporation of thymidine
analogs has been demonstrated in rd1 photoreceptors, and this
could reflect either ongoing DNA repair in diseased cells44 or a
failed attempt to re-enter the cell cycle.25 In either case, the
effect of decitabine treatment suggests that there has been an
increase in DNA methylation during the rd1 degeneration,
which somehow contributes to cell death. However, it has been
suggested that the execution of apoptosis is not compatiblewith
concomitant DNA synthesis.45 Taken together, our findings thus
point to the presence of non-apoptotic mechanisms during
photoreceptor death,39 in which epigenetic processes have a
preeminent role.
Conclusion
In summary, we have demonstrated increased DNA methyla-
tion in photoreceptor degeneration in four different models of
RP in two different species. The methylated DNA immuno-
precipitation (MeDIP) and microarray data-based analyses
revealed transcriptional silencing via cytosinemethylation as a
new player in the degeneration mechanism and provided us
with fresh entry points for further investigations. Our analysis
highlighted the importance of differential methylation patterns
in individual rd1 and wt genes. Finally, DNMT inhibition
delayed retinal degeneration suggesting DNA methylation as
a common denominator during photoreceptor cell death and
emphasizing the potential of DNMT inhibitors for mutation-
independent neuroprotection in RP.
Materials and Methods
Animals. Animals were kept under standard white cyclic lighting, with ad libitum
access to food and water, and were used irrespective of gender. Four different
mouse and rat mutant lines were used, together with the corresponding wild-type
lines (see Table 1). P23H and S334ter rhodopsin transgenic rats were kindly
provided by Dr. M M LaVail (University of California, San Francisco, CA, USA). All
procedures were performed in accordance with either the Swedish (rd1 and rd2, wt
mice; permit nos. M242/07 and M220/09) and German (S334ter, P23H and CD rats,
Table 1 Animal strains and species used in this study; affected genes, effects, and original references
Strain and species Mutated gene Effect Ages used Reference
C3H wild-type mouse — — PN11/PN19 56
C3H rd1 mouse Pde6b cGMP accumulation, rapid rod photoreceptor degeneration, onset
≤PN10, concluded ≥PN21
PN11a 13,20
C3H rd2 mouse Prph2 No outer segment formation, slow rod and cone degeneration, onset
≤PN16, concluded ≥PN180
PN19 57
CD(S.D.) wild-type rat — — PN12/PN15 —
CD(S.D.) P23H rat Rho (P23H tg) Rhodopsin misfolding, rod degeneration, onset ≤PN15, concluded
≥PN90
PN15 58
CD(S.D.) S334ter rat Rho (S334ter tg) Rhodopsin truncation, very rapid rod degeneration, onset ≤PN10,
concluded ≥PN18
PN12 59
aFor rd1 mice, we also used PN7, PN9, PN11, PN13, and PN15 for temporal analysis of 5mC detection
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Anzeige/Mitteilung nach § 4 vom 28.04.08 and 29.04.10) animal care and ethics
committees. Efforts were made to keep the number of animals used and their
suffering to a minimum, and the experiments followed the ARVO statement for the
use of animals in ophthalmic and visual research.
For biochemical analyses and comparisons between mutant and wild-type tissues,
we used material from ages corresponding to phases where the degeneration is
under way (see Table 1), but where the loss of retinal tissue is still minimal, reducing
the risk for technical bias.46,47 For rd1, this was PN 11; for rd2 mice PN19; for Rho
P23H rats PN15; and for Rho S334ter rats PN12. For the temporal analysis of 5mC
detection, we used rd1 mouse retinae from PN7, PN9, PN11, PN13, and PN15.
Organotypic retinal explant culture. Tissue was obtained from PN5 rd1
animals that were killed by decapitation, after which the eyes were enucleated and
retinae cultured as previously described.4,48 In brief, the retina and the retinal
pigment epithelium (RPE) were isolated and subsequently transferred to a Millicell
culture dish filter insert (Millipore AB, Solna, Sweden; PIHA03050), with the RPE
layer facing the culturing membrane and incubated in R16 nutrient medium at 37 °C.
The full volume of nutrient medium, 1.5 ml per dish, was replaced with fresh
medium every second day (with the exception of the one-day treatment experiments
below) during the culturing period.
PN5 explants were allowed to adjust to culture conditions for 2 days in vitro.
Cultures were then treated with 5-aza-2’deoxycitydine (decitabine, no. A-3656,
Sigma, Stockholm, Sweden) every second day for 4 days reaching the equivalent to
PN11 (short term: PN5+2 days in vitro+4 days in vitro with treatment) or to PN19 (long
term: PN5+2 days in vitro +12 days in vitro with treatment). The cultures assigned for
treatment were given 0.5, 1.25, 2.5, 5, or 10 μM of decitabine. Quantification of cells
positive for the cell death marker TUNEL (see below) and counting of surviving
photoreceptor rows represented the readout for short- and long-term cultures. All
treatment experiments were done in a paired fashion, with treated and untreated
samples from one animal processed together. Thus, treated/untreated samples were
stained under the exact same conditions.
Fixation, sectioning, and microscopy. Enucleated mouse and rat eyes
and cultured retinae were fixed in 4% PFA in PBS at 4 °C for 2 and 1 h for mouse
and rat, respectively. Eyes were cryoprotected in Sorensen’s sucrose buffer and
processed to 12-μm cryosections.
Routine morphological observations were performed on a Zeiss Axiophot (Zeiss,
Jena, Germany) microscope equipped with a Zeiss Axiocam (Zeiss) digital camera.
Fluorescence excitation was provided by a HBO 100W halogen lamp. Images were
taken by means of the Zeiss Axiovision 4.2 software; images elaboration and overlays
were performed utilizing Adobe Photoshop CS (San Jose, CA, USA).
Terminal dUTP nick-end labeling. TUNEL staining on fixed preparations
was performed using an in situ kit (In Situ Cell Death Detection Kit; TMR Red,
Roche, Mannheim, Germany). Controls with this kit and similar preparations were
performed by omitting the terminal deoxynucleotidyl transferase enzyme from the
labeling solution (negative control) and by pretreating the sections for 30 min with
DNAse I (Roche, 3 U/ml) in 50 mM Tris-HCl, pH 7.5, 1 mg/ml BSA to induce DNA
strand breaks (positive control).3
Histological staining and immunofluorescence. Fixed sections were
stained for general histological light microscopic analysis with hematoxylin–eosin
(HE) according to the standard protocols or underwent immunostaining. For the
latter, the sections were washed 3 × 5 min each in PBS containing 0.25% Triton
X100 (PTX) plus 1% BSA. Blocking solution consisting of PTX with 5% normal
serum from the host animal, from which the secondary antibody was obtained, was
applied for 45 min. Primary antibodies were diluted in PBS with 1% BSA and 0.25%
Triton X100 and applied overnight at 4 °C. Sections were then washed 3 × 5 min
each in PTX and incubated with the appropriate secondary antibodies diluted in
PTX for 45 min. After three more washing steps in PBS, the sections were mounted
with Vectashield DAPI (Vector, Burlingame, CA, USA). Controls consisted of
sections processed in parallel without primary antibody and application of the
fluorescence detection system.
5mC results were obtained with the sheep anti-5mC antibody (Novus Biologicals,
Cambridge, UK; category no. NB-100-744, working dilution 1 : 200) and confirmed
with two other anti-5mC antibodies (Abcam, Cambridge, UK, Ab10805; 1 : 1000 and
Ab51552; 1 : 50, data not shown). To exclude the possibility of unspecific antibody
binding to DNA in degenerating nuclei, we also performed pretreatment of rd1 and wt
sections with 3 N HCl, which denatures the DNA. This yielded a weak and general
nuclear staining of most retinal cells, but there was still a clear difference between the
rd1 and wt retinae, in that a subset of rd1 photoreceptor nuclei attained a strong
immunostaining that was not present in the wt situation (Supplementary Figure S1). In
the 5mC staining in sections without pretreatment (see Figures 3a–d and also Figures
1c and d), there is, in principle, no positive nuclei outside of the brightly stained ones
of the rd1 ONL.
Confocal microscopy. Samples were analyzed with a Zeiss 510 Meta
confocal laser scanning microscope (Department of Biology, Lund University, Lund,
Germany). The 488-nm line of a 30 mW Ar ion laser was used for AF488 excitation,
and a 405-nm 15-mW solid-state laser for DAPI excitation. DAPI fluorescence was
detected using a 420–480-nm bandpass filter, and AF488 with a 505–550-nm
bandpass filter. A 63 × /1.5 Plan Apochromat oil immersion objective was used. The
pinhole diameter was 1.0 Airy unit (giving optical sections of about 0.6 μm when
using the 63 × /1.5 objective). Optical sections for z-stacks were sampled with 50%
overlap, that is, with a step size of 0.30 μm. For presentation in Figures 1c and d,
we used maximum intensity projections, based on 16 and 21 Z-sections,
respectively.
Counting of cells. The number of TUNEL- or 5mC-positive (+) cells was
assessed and calculated as reported previously.49,50 For each animal, at least three
sections were quantified to yield an average value, and at least three different
animals were analyzed for each experimental situation. Values are given as TUNEL
(+) cells relative to control±S.D. Statistical significance was tested using either
paired or unpaired two-tailed Student’s t-test or ANOVA test as indicated. For all
tests, a P-value o0.05 was considered to indicate a statistically significant
difference.
Electron microscopy. Analysis of degenerating and normal retinae was also
performed at the electron microscopy (EM) level using the standard methods for
transmission EM. In brief, whole eyes of mouse were enucleated and quickly
punctured to improve fixative penetration. The eyes were then fixed in 2%
glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer
overnight. The specimens were then postfixed in 1% osmium tetraoxide for 1 h, after
which they were dehydrated in an ethanol series followed by acetone and
embedded in Epon resin. Ultrathin sections about 50-nm thick were cut on a Leica
UCT ultramicrotome (Leica Microsystems, Wetzlar, Germany), placed on single-slot
grids, and stained with 2% uranylacetate for 30 min and lead citrate for 3 min. The
sections were viewed in a JEOL 1230 transmission electron microscope (JEOL,
Tokyo, Japan), and digital pictures with a resolution of 1024 × 1024 pixels were
taken using a GATAN Multiscan camera (GATAN, Abingdon Oxon, UK).
Methylated DNA immunoprecipitation. MeDIP was performed according
to the protocol provided from Roche-NimbleGen (Madison, WI, USA). In detail, DNA
was extracted from PN11 wt and rd1 retinae with DNeasy kit (No. 69504, Qiagen,
Hilden, Germany) according to the manufacturer’s instructions. The analysis
encompassed two samples of each genotype, with each sample being produced by
using two retinae. DNA was incubated overnight at 37 °C with MseI restriction
enzyme (No. R0525S, New England Biolabs, Ipswich, MA, USA), which cuts
unmethylated sequences only. The buffer provided by the company was
supplemented with 100 ng/μl BSA, and the reaction ran overnight at 37 °C.
Digested DNA samples were purified using the QIAquick PCR Purification Kit (No.
28104, Qiagen) according to the manufacturer’s instructions. A volume of 1.25 μl of
purified DNA was then diluted in 300 μl of TE buffer (10 mM Tris HCl, pH 7,5; 1 mM
EDTA) and heat denatured at 95 °C for 10 min. Of this, 60 μl (250 ng) were removed
and stored as input control, while to the remaining DNA, 60 μl of 5 × IP buffer
(100 mM Na-phosphate, pH 7,0; 5 M NaCl; 10% Triton X-100; ddH2O until final
volume) were added. Samples were immunoprecipitated using a mouse anti 5-
methylcytidine antibody (Ab10805, Abcam) with a 1 : 1 ratio of antibody:DNA. The
DNA:antibody mixture was incubated overnight at 4 °C on a slowly rotating platform
to avoid foaming. Antibody conjugation to beads of protein A-agarose (No. 15918-
014, Invitrogen, Carlsbad, CA, USA) was performed for 2 h at 4 °C by gentle rolling.
After washing the beads in 1 × IP buffer, they were centrifuged at 6000 r.p.m.
(= 3800 × g) for 2 min at 4 °C, and the supernatant was discarded. Washing was
repeated twice, and the beads were finally resuspended in 250-μl digestion buffer
(1 M Tris HCl, pH 8,0; 0,5 M EDTA; 10% SDS; ddH2O until final volume).
To resuspend the beads, 7 μl (10 mg/ml) of proteinase K (No. 03115836011, Roche
Applied Science, Penzberg, Germany) was added. Microcentrifuge tubes containing
the antibody–beads complex and DNA were then sealed with Parafilm and placed in
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50-ml Falcon tubes filled with damp paper towel to avoid evaporation and incubated
overnight on a rotating platform at 55 °C. To purify the samples, 250 μl of phenol
(No. P-4557, Sigma Aldrich) was added. Methylated DNA samples were vortexed
for 30 s and centrifuged at 14 000 r.p.m. (= 20800 × g) for 5 min at room
temperature. The aqueous supernatant was saved and transferred to sterile
microcentrifuge tubes. The former step was then repeated but with the addition of
250 μl of chloroform:isoamyl alcohol (No. C-0549, Sigma Aldrich). To pellet DNA-
purified samples, 1 μl of glycogen (No. 10901393001, Roche Applied Science),
20 μl of 5 M NaCl, and 500 μl of ethanol were added, and precipitation of the
samples occurred after incubation for 30 min at − 80 °C. The pellets were
centrifuged at 14 000 r.p.m. (= 20800 × g) for 15 min at 4 °C; the supernatants were
carefully removed, and samples were washed in 500 μl of cold 70% ethanol.
Centrifugation was repeated, and samples were dried in a centrifugal evaporator
and resuspended in 30 μl of 10 mM Tris HCl (pH 8,5). We amplified 10 ng of
immunoprecipitated and input DNA using the GenomePlex Complete Whole
Genome Amplification (WGA) kit (No. WGA2-50RXN, Sigma Aldrich) according to
the manufacturer’s instructions. Finally, each sample was further purified with the
Qiagen QIAquick PCR purification Kit (see step 2) according to the manufacturer’s
protocol. Samples were then ready for analysis by microarray (2.1M Deluxe
Promoters, NimbleGen) covering 490% of the known gene promoters in the
mouse DNA.
Bioinformatics. Genome-wide binding data was analyzed with utilities in the
cistrome portal.51 In brief, peak enrichment was analyzed by Model-based analysis
of two-color arrays (MA2C) for ChIP-chip (Nimblegen) using the following
parameters: bandwidth 300, max gap 250, min probes 5, threshold method
P-value, value, 10− 6, normalization method robust, C value 2, and mm9 assembly.
Multiple wiggle file correlation was performed using methylated peak locations of wt
and rd1. The Cistrome/Galaxy ‘integrative analysis – peak2gene’ tool was used to
retrieve all annotated genes located within 30 kb of the methylated sites and 1 kB of
transcription factor-binding sites. Heatmap was generated using k-means cluster
method and applying a k-means number of 5. The SitePro: Aggregation plot tool for
signal profiling (version 1.0.0) was utilized to draw the average score profile around
given genomic sites. Genomic location annotation and enrichment profiling was
performed using CEAS (version 1.0.0.) by calculating average signal reads to
generate average profile plots using the following parameters: Span 3000, Profiling
resolution 50, Promoter/downstream lower-interval 1000, Promoter/downstream
middle-interval 2000, Promoter/downstream upper-interval 3000, Bi-Promoter lower
range 2500, Bi-Promoter upper range 5000, and Relative distance 3000. Motif
analysis was performed by using the SeqPos Tool (version 1.0.0.) using a P-value
cutoff of 0.001 and a scanning width of 600. Gene ontology analysis and pathway
analysis was conducted using Database for Annotation, Visualization and Integrated
Discovery. A previous microarray analysis compared the gene expression profiles of
retinae from PN11 rd1 and wt animals.2 Here, we used its BASE data to study the
correlation of methylation with gene expression.
RNA-extraction/RT-qPCR. Total RNA extraction was performed using the
RNeasy-Mini Kit (Qiagen) according to the manufacturer’s protocol. RNA quality
was analyzed on an Agilent Bioanalyzer (Agilent Technologies, Waldbronn,
Germany). RT-PCR was performed using the ThermoScript RT-PCR System
(Invitrogen, Darmstadt, Germany). qPCR was performed on a LightCycler 480
System (Roche Applied Science) using KAPA SYBR FAST (Peqlab, Erlangen,
Germany). Three different biological samples were analyzed in duplicates and
normalized to the expression of the housekeeping gene aminolevulinic acid
synthase (ALAS). Relative quantification was determined by the method described
by Pfaffl.52 The following primers were used (5′→ 3′ orientation): DNMT1 fwd.: CAT
ATCTGCAAGGACATGAG, DNMT1 rev.: CACATCATGAAAGGTCTACTG, DNMT3A
fwd.: GCACGTTGGAAAGGGAGGCTGA, DNMT3A rev.: AGAAGCAGGGTCCGTG
GGCT, DNMT3B fwd.: TGGCACCCTCTTCTTCATTC, DNMT3B rev.: ATATACCTT
TCCAGACGCGG, DNMT3L fwd.: AGCTTGCTCCTGCTTCTGA, DNMT3L rev.:CGT
GGCAGAGACTACCAGAA, ALAS fwd.: TCGCCGATGCCCATTCTTATC, and ALAS
rev.: GGCCCCAACTTCCATCATCT.
Three different biological samples were analyzed in duplicates and normalized to
the expression of the housekeeping gene ALAS. Relative quantification was
determined.
High-performance liquid chromatography coupled with mass
spectrometry. Samples (97 μl injection volume) were chromatographed by a
Dionex Ultimate 3000 HPLC system (Dionex, Idstein, Germany) with a flow of
0.15 ml/min over an Uptisphere UP3HDO-150/21 column (3 μm, 2.1 mm × 150 mm)
from Interchim (Interchim, Mannheim, Germany). The column temperature was
maintained at 30 °C. The gradient (buffer A: 0.01% formic acid in H2O; buffer B:
0.01% formic acid in 95% MeCN/5% H2O) was the following: 0→ 12 min; 0%→ 1%
buffer B; 12→ 20 min; 1%→ 2% buffer B; 20→ 30 min; 2%→ 10% buffer B;
30→ 35 min; 10%→ 80% buffer B; 35→ 41 min; 80% buffer B; 41→ 51 min;
80%→ 0% buffer B; and 51→ 60 min; 0% buffer B. Sample elution was monitored
at 260 nm (Dionex Ultimate 3000 Diode Array Detector). The effluent from the first
5 min (total run time of 60min) was diverted to waste by a Valco (Macherey-Nagel
GmbH and Co. KG, Düren, Germany) valve to protect the mass spectrometer. The
subsequent chromatographic effluent was directly injected into the ion source of a
Thermo Finnigan LTQ Orbitrap XL (ThermoFinnigan, Bremen, Germany) without
prior splitting. Ions were scanned using a positive polarity mode over a full-scan
range of m/z 100–500 with a resolution of 30 000. The absolute amounts of 5mC
were determined by a stable isotope dilution method and then related to the dG
content by UV-detection giving the relative values in percentage. Two technical
replicates per sample were performed.53–55
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